Loading...

John Kurhanewicz, PhD

Title(s)Professor, Radiology
SchoolSchool of Medicine
Address1700 4th St
San Francisco CA 94158
Phone415-514-9655
ORCID ORCID Icon0000-0002-3544-5339 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Academy of Radiology Research 2013Distinguished Investigator
    International Society for Magnetic Resonance in Medicine2009GE Healthcare’s MR Thought Leader
    University of California, San Francisco School of Pharmacy2009Dean’s Recognition for Excellence in Teaching
    Society of Magnetic Resonance in Medicine2008Fellow
    International Society for Magnetic Resonance in Medicine2007  - 2008Outstanding Teacher Award
    University of South Florida1998Outstanding Chemistry Alumnus

    Collapse Overview 
    Collapse Overview
    John Kurhanewicz, PhD is a Professor in Residence in the Departments of Radiology and Biomedical Imaging, Urology and Pharmaceutical Chemistry at University of California, San Francisco, and a member of the California Institute for Quantitative Biology and UCSF Cancer Center, and faculty in the UCSF-UCB Bioengineering Graduate Group. He is the Director of the UCSF Body Research Interest Group, the Biomedical NMR lab, and the Kurhanewicz Laboratory at UCSF. Dr. Kurhanewicz received his BS in Chemistry from the University of South Florida/New College in 1982, and obtained his PhD in Physical Organic Chemistry from the University of South Florida, Tampa in 1987, followed by a postdoctoral fellowship in MRI/MRS from the University of California, San Francisco in 1990.

    Dr. Kurhanewicz and his colleagues have developed a large prostate cancer imaging program at UCSF, involving the application of advanced magnetic resonance imaging techniques (metabolic, diffusion and perfusion weighted MRI) to provide a more accurate assessment of the extent and aggressiveness of prostate cancer in individual patients. This multiparametric 1H MRI prostate cancer staging exam is currently being used to help over a 1,000 men diagnosed with prostate cancer a year at UCSF to decide on their best therapeutic course. He is also currently involved in the development and clinical translation of an extraordinary new molecular imaging technique utilizing hyperpolarized 13C labeled metabolic substrates that has the potential to revolutionize the way MR imaging is used in the risk assessment of prostate cancer patients. He led the first clinical trial of this technology at UCSF and is involved in three ongoing clinical trials investigating its clinical utility.

    Dr. Kurhanewicz has published over 230 peer-reviewed manuscripts and19 book chapters, and has been cited 16,089 times (citation indices: h-index of 69, i10-index - 180). He is a member of 7 scientific societies, serves on numerous scientific review panels for the National Institute of Health, Department of Defense and American Cancer Society and reviews for over 20 different journals. He has 25 years of mentoring in the areas of advanced MR cancer imaging and molecular imaging, and has mentored over 120 graduate and under-graduate students, medical fellows and junior faculty.

    Expertise:
    Urology

    Specialty:
    Prostate cancer, urology, pharmaceutical chemistry

    Professional Interests:
    Magnetic resonance imaging, magnetic resonance spectroscopy, hyperpolarized 13C MR cancer, dynamic nuclear polarization, hyperpolarized probes, micro-imaging, diffusion tensor imaging, dynamic contrast enhanced imaging, prostate cancer, imaging biomarkers, high-resolution magic angle spinning (HR-MAS) spectroscopy, 13C and 31P spectroscopy, immunohistochemistry, gene expression, clinical translation

    Education and Training:
    • Bachelor of Science: University of South Florida/New College - BS, Chemistry
    • Doctor of Philosophy: University of South Florida, Tampa - Physical Chemistry
    • Postdoctoral Fellowship: University of California, San Francisco - Vivo MRI/MRS

    Collapse Research 
    Collapse Research Activities and Funding
    Metabolic imaging comparisons of patient-derived models of renal cell carcinoma
    NIH/NCI U01CA217456Sep 1, 2017 - Jul 31, 2022
    Role: Principal Investigator
    Targeting Neuroendocrine Prostate Cancer Using Multi-Probe Hyperpolarized 13C MRI for Improved Treatment and Therapeutic Monitoring
    NIH/NCI R01CA215694Jun 1, 2017 - May 31, 2022
    Role: Principal Investigator
    CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING
    NIH/NCI R01CA214554Mar 6, 2017 - Feb 28, 2022
    Role: Principal Investigator
    Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods
    NIH/NIBIB R01EB017449Aug 15, 2013 - Jul 31, 2018
    Role: Co-Principal Investigator
    New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI
    NIH/NIBIB R01EB013427Jul 15, 2013 - May 31, 2017
    Role: Co-Principal Investigator
    Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy
    NIH/NCI R01CA166655Sep 30, 2012 - Jul 31, 2017
    Role: Principal Investigator
    PET and MR-Compatible Bioreactor for Cross-Platform Biomarker Development
    NIH/NCI R21CA171766Aug 1, 2012 - Jul 31, 2014
    Role: Co-Principal Investigator
    Hyperpolarized MRI Technology Resource Center
    NIH/NIBIB P41EB013598Jul 1, 2011 - May 31, 2021
    Role: Co-Investigator
    Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam
    NIH/NCI R01CA137207Aug 9, 2010 - Jun 30, 2015
    Role: Principal Investigator
    Hyperpolarized High Field NMR Facility For Metabolic Profiling Of Human Disease
    NIH/NCRR S10RR024587Feb 15, 2008 - Feb 14, 2009
    Role: Principal Investigator
    TECHNIQUE DEVELOPMENT FOR HYPERPOLARIZED C-13 MR STUDIES
    NIH/NIBIB R01EB007588Aug 15, 2007 - Sep 29, 2011
    Role: Co-Principal Investigator
    High Field NMR System for Metabolic Imaging of Human Disease
    NIH/NCRR S10RR023013Jun 1, 2007 - Nov 30, 2009
    Role: Principal Investigator
    Hyperpolarized 13c NMR Studies of Prostate Cancer (RMI)
    NIH/NIBIB R21EB005363Sep 15, 2005 - Aug 31, 2010
    Role: Principal Investigator
    MR Based Molecular Imaging of Prostate Cancer
    NIH/NCI R01CA102751Jan 25, 2005 - Dec 31, 2010
    Role: Principal Investigator
    IMPROVED MRI/MRSI FOR BIOPSY GUIDANCE OF PROSTATE CANCER
    NIH/NCI R33CA088214Sep 28, 2000 - Aug 31, 2004
    Role: Principal Investigator
    Monitoring Radiation Therapy of Prostate Cancer by MRSI
    NIH/NCI R01CA079980Feb 5, 1999 - Jun 30, 2010
    Role: Principal Investigator
    METABOLIC STUDIES OF RESPONSE TO PROSTATE CANCER THERAPY
    NIH/NCI R29CA064667Mar 1, 1996 - Feb 28, 2002
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tensor image enhancement and optimal multichannel receiver combination analyses for human hyperpolarized 13 C MRSI. Magn Reson Med. 2020 Jun 05. Chen HY, Autry AW, Brender JR, Kishimoto S, Krishna MC, Vareth M, Bok RA, Reed GD, Carvajal L, Gordon JW, van Criekinge M, Korenchan DE, Chen AP, Xu D, Li Y, Chang SM, Kurhanewicz J, Larson PEZ, Vigneron DB. PMID: 32501614.
      View in: PubMed   Mentions:    Fields:    
    2. Simultaneous Metabolic and Perfusion Imaging Using Hyperpolarized 13C MRI Can Evaluate Early and Dose-Dependent Response to Radiation Therapy in a Prostate Cancer Mouse Model. Int J Radiat Oncol Biol Phys. 2020 Apr 25. Qin H, Zhang V, Bok RA, Santos RD, Cunha JA, Hsu IC, Santos Bs JD, Lee JE, Sukumar S, Larson PEZ, Vigneron DB, Wilson DM, Sriram R, Kurhanewicz J. PMID: 32339646.
      View in: PubMed   Mentions:    Fields:    
    3. Hyperpolarized 13 C MRI data acquisition and analysis in prostate and brain at University of California, San Francisco. NMR Biomed. 2020 Mar 19; e4280. Crane JC, Gordon JW, Chen HY, Autry AW, Li Y, Olson MP, Kurhanewicz J, Vigneron DB, Larson PEZ, Xu D. PMID: 32189442.
      View in: PubMed   Mentions:    Fields:    
    4. Elevated Tumor Lactate and Efflux in High-grade Prostate Cancer demonstrated by Hyperpolarized 13C Magnetic Resonance Spectroscopy of Prostate Tissue Slice Cultures. Cancers (Basel). 2020 Feb 26; 12(3). Sriram R, Van Criekinge M, DeLos Santos J, Ahamed F, Qin H, Nolley R, Santos RD, Tabatabai ZL, Bok RA, Keshari KR, Vigneron DB, Peehl DM, Kurhanewicz J. PMID: 32110965.
      View in: PubMed   Mentions:
    5. Hyperpolarized 13C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study. Prostate Cancer Prostatic Dis. 2020 Jun; 23(2):269-276. Chen HY, Aggarwal R, Bok RA, Ohliger MA, Zhu Z, Lee P, Gordon JW, van Criekinge M, Carvajal L, Slater JB, Larson PEZ, Small EJ, Kurhanewicz J, Vigneron DB. PMID: 31685983.
      View in: PubMed   Mentions: 1     Fields:    
    6. Hyperpolarized in vivo pH imaging reveals grade-dependent acidification in prostate cancer. Oncotarget. 2019 Oct 22; 10(58):6096-6110. Korenchan DE, Bok R, Sriram R, Liu K, Santos RD, Qin H, Lobach I, Korn N, Wilson DM, Kurhanewicz J, Flavell RR. PMID: 31692908.
      View in: PubMed   Mentions:    Fields:    
    7. First hyperpolarized [2-13C]pyruvate MR studies of human brain metabolism. J Magn Reson. 2019 12; 309:106617. Chung BT, Chen HY, Gordon J, Mammoli D, Sriram R, Autry AW, Le Page LM, Chaumeil MM, Shin P, Slater J, Tan CT, Suszczynski C, Chang S, Li Y, Bok RA, Ronen SM, Larson PEZ, Kurhanewicz J, Vigneron DB. PMID: 31648132.
      View in: PubMed   Mentions: 2     Fields:    
    8. Amino Acid-Derived Sensors for Specific Zn2+ Detection Using Hyperpolarized 13 C Magnetic Resonance Spectroscopy. Chemistry. 2019 Sep 12; 25(51):11842-11846. Wang S, Korenchan DE, Perez PM, Taglang C, Hayes TR, Sriram R, Bok R, Hong AS, Wu Y, Li H, Wang Z, Kurhanewicz J, Wilson DM, Flavell RR. PMID: 31338914.
      View in: PubMed   Mentions:    Fields:    
    9. Zero-field nuclear magnetic resonance of chemically exchanging systems. Nat Commun. 2019 07 05; 10(1):3002. Barskiy DA, Tayler MCD, Marco-Rius I, Kurhanewicz J, Vigneron DB, Cikrikci S, Aydogdu A, Reh M, Pravdivtsev AN, Hövener JB, Blanchard JW, Wu T, Budker D, Pines A. PMID: 31278303.
      View in: PubMed   Mentions:    Fields:    
    10. Using bidirectional chemical exchange for improved hyperpolarized [13 C]bicarbonate pH imaging. Magn Reson Med. 2019 09; 82(3):959-972. Korenchan DE, Gordon JW, Subramaniam S, Sriram R, Baligand C, VanCriekinge M, Bok R, Vigneron DB, Wilson DM, Larson PEZ, Kurhanewicz J, Flavell RR. PMID: 31050049.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    11. Measuring Dynamic Changes in the Labile Iron Pool in Vivo with a Reactivity-Based Probe for Positron Emission Tomography. ACS Cent Sci. 2019 Apr 24; 5(4):727-736. Muir RK, Zhao N, Wei J, Wang YH, Moroz A, Huang Y, Chen YC, Sriram R, Kurhanewicz J, Ruggero D, Renslo AR, Evans MJ. PMID: 31041393.
      View in: PubMed   Mentions:
    12. NMR quantification of lactate production and efflux and glutamate fractional enrichment in living human prostate biopsies cultured with [1,6-13 C2 ]glucose. Magn Reson Med. 2019 08; 82(2):566-576. Bancroft Brown J, Sriram R, VanCriekinge M, Delos Santos R, Sun J, Delos Santos J, Tabatabai ZL, Shinohara K, Nguyen H, Peehl DM, Kurhanewicz J. PMID: 30924180.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Hyperpolarized 13C MRI: State of the Art and Future Directions. Radiology. 2019 05; 291(2):273-284. Wang ZJ, Ohliger MA, Larson PEZ, Gordon JW, Bok RA, Slater J, Villanueva-Meyer JE, Hess CP, Kurhanewicz J, Vigneron DB. PMID: 30835184.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. The Role of Lactate Metabolism in Prostate Cancer Progression and Metastases Revealed by Dual-Agent Hyperpolarized 13C MRSI. Cancers (Basel). 2019 Feb 22; 11(2). Bok R, Lee J, Sriram R, Keshari K, Sukumar S, Daneshmandi S, Korenchan DE, Flavell RR, Vigneron DB, Kurhanewicz J, Seth P. PMID: 30813322.
      View in: PubMed   Mentions:
    15. Coil combination methods for multi-channel hyperpolarized 13C imaging data from human studies. J Magn Reson. 2019 04; 301:73-79. Zhu Z, Zhu X, Ohliger MA, Tang S, Cao P, Carvajal L, Autry AW, Li Y, Kurhanewicz J, Chang S, Aggarwal R, Munster P, Xu D, Larson PEZ, Vigneron DB, Gordon JW. PMID: 30851668.
      View in: PubMed   Mentions:    Fields:    
    16. Pulse sequence considerations for quantification of pyruvate-to-lactate conversion kPL in hyperpolarized 13 C imaging. NMR Biomed. 2019 03; 32(3):e4052. Chen HY, Gordon JW, Bok RA, Cao P, von Morze C, van Criekinge M, Milshteyn E, Carvajal L, Hurd RE, Kurhanewicz J, Vigneron DB, Larson PEZ. PMID: 30664305.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    17. Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology. Neoplasia. 2019 01; 21(1):1-16. Kurhanewicz J, Vigneron DB, Ardenkjaer-Larsen JH, Bankson JA, Brindle K, Cunningham CH, Gallagher FA, Keshari KR, Kjaer A, Laustsen C, Mankoff DA, Merritt ME, Nelson SJ, Pauly JM, Lee P, Ronen S, Tyler DJ, Rajan SS, Spielman DM, Wald L, Zhang X, Malloy CR, Rizi R. PMID: 30472500.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    18. Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer. J Nucl Med. 2019 07; 60(7):910-916. Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, Greene KL, Langton-Webster B, Berkman CE, Seo Y. PMID: 30464040.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    19. Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients. Magn Reson Med. 2019 04; 81(4):2702-2709. Gordon JW, Chen HY, Autry A, Park I, Van Criekinge M, Mammoli D, Milshteyn E, Bok R, Xu D, Li Y, Aggarwal R, Chang S, Slater JB, Ferrone M, Nelson S, Kurhanewicz J, Larson PEZ, Vigneron DB. PMID: 30375043.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Dynamic diffusion-weighted hyperpolarized 13 C imaging based on a slice-selective double spin echo sequence for measurements of cellular transport. Magn Reson Med. 2019 03; 81(3):2001-2010. Zhu X, Gordon JW, Bok RA, Kurhanewicz J, Larson PEZ. PMID: 30368893.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    21. Investigation of analysis methods for hyperpolarized 13C-pyruvate metabolic MRI in prostate cancer patients. NMR Biomed. 2018 11; 31(11):e3997. Larson PEZ, Chen HY, Gordon JW, Korn N, Maidens J, Arcak M, Tang S, Criekinge M, Carvajal L, Mammoli D, Bok R, Aggarwal R, Ferrone M, Slater JB, Nelson SJ, Kurhanewicz J, Vigneron DB. PMID: 30230646.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Non-Invasive Assessment of Lactate Production and Compartmentalization in Renal Cell Carcinomas Using Hyperpolarized 13C Pyruvate MRI. Cancers (Basel). 2018 Sep 05; 10(9). Sriram R, Gordon J, Baligand C, Ahamed F, Delos Santos J, Qin H, Bok RA, Vigneron DB, Kurhanewicz J, Larson PEZ, Wang ZJ. PMID: 30189677.
      View in: PubMed   Mentions:
    23. Assessing high-intensity focused ultrasound treatment of prostate cancer with hyperpolarized 13 C dual-agent imaging of metabolism and perfusion. NMR Biomed. 2019 10; 32(10):e3962. Lee JE, Diederich CJ, Bok R, Sriram R, Santos RD, Noworolski SM, Salgaonkar VA, Adams MS, Vigneron DB, Kurhanewicz J. PMID: 30022550.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    24. Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv. 2018 07 10; 2(13):1595-1607. Rubenstein JL, Geng H, Fraser EJ, Formaker P, Chen L, Sharma J, Killea P, Choi K, Ventura J, Kurhanewicz J, Lowell C, Hwang J, Treseler P, Sneed PK, Li J, Wang X, Chen N, Gangoiti J, Munster PN, Damato B. PMID: 29986852.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    25. Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy. J Contemp Brachytherapy. 2018 Jun; 10(3):193-201. Chapman CH, Braunstein SE, Pouliot J, Noworolski SM, Weinberg V, Cunha A, Kurhanewicz J, Gottschalk AR, Roach MI, Hsu IC. PMID: 30038638.
      View in: PubMed   Mentions:
    26. Spatio-Temporally Constrained Reconstruction for Hyperpolarized Carbon-13 MRI Using Kinetic Models. IEEE Trans Med Imaging. 2018 12; 37(12):2603-2612. Maidens J, Gordon JW, Chen HY, Park I, Van Criekinge M, Milshteyn E, Bok R, Aggarwal R, Ferrone M, Slater JB, Kurhanewicz J, Vigneron DB, Arcak M, Larson PEZ. PMID: 29994332.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    27. Molecular detection of inflammation in cell models using hyperpolarized 13C-pyruvate. Theranostics. 2018; 8(12):3400-3407. Sriram R, Nguyen J, Santos JD, Nguyen L, Sun J, Vigneron S, Van Criekinge M, Kurhanewicz J, MacKenzie JD. PMID: 29930738.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    28. Imaging glutathione depletion in the rat brain using ascorbate-derived hyperpolarized MR and PET probes. Sci Rep. 2018 05 21; 8(1):7928. Qin H, Carroll VN, Sriram R, Villanueva-Meyer JE, von Morze C, Wang ZJ, Mutch CA, Keshari KR, Flavell RR, Kurhanewicz J, Wilson DM. PMID: 29786697.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    29. Late-stage deuteration of 13C-enriched substrates for T1 prolongation in hyperpolarized 13C MRI. Chem Commun (Camb). 2018 May 17; 54(41):5233-5236. Taglang C, Korenchan DE, von Morze C, Yu J, Najac C, Wang S, Blecha JE, Subramaniam S, Bok R, VanBrocklin HF, Vigneron DB, Ronen SM, Sriram R, Kurhanewicz J, Wilson DM, Flavell RR. PMID: 29726563.
      View in: PubMed   Mentions: 1     Fields:    
    30. Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget. 2018 Apr 17; 9(29):20399-20408. Truillet C, Parker MFL, Huynh LT, Wei J, Jami KM, Wang YH, Shen YS, Sriram R, Wilson DM, Kurhanewicz J, Evans MJ. PMID: 29755660.
      View in: PubMed   Mentions:    Fields:    
    31. Technique development of 3D dynamic CS-EPSI for hyperpolarized 13 C pyruvate MR molecular imaging of human prostate cancer. Magn Reson Med. 2018 11; 80(5):2062-2072. Chen HY, Larson PEZ, Gordon JW, Bok RA, Ferrone M, van Criekinge M, Carvajal L, Cao P, Pauly JM, Kerr AB, Park I, Slater JB, Nelson SJ, Munster PN, Aggarwal R, Kurhanewicz J, Vigneron DB. PMID: 29575178.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    32. In vivo hyperpolarization transfer in a clinical MRI scanner. Magn Reson Med. 2018 08; 80(2):480-487. von Morze C, Reed GD, Larson PE, Mammoli D, Chen AP, Tropp J, Van Criekinge M, Ohliger MA, Kurhanewicz J, Vigneron DB, Merritt ME. PMID: 29488244.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    33. Detection of Bacteria-Specific Metabolism Using Hyperpolarized [2-13C]Pyruvate. ACS Infect Dis. 2018 05 11; 4(5):797-805. Sriram R, Sun J, Villanueva-Meyer J, Mutch C, De Los Santos J, Peters J, Korenchan DE, Neumann K, Van Criekinge M, Kurhanewicz J, Rosenberg O, Wilson D, Ohliger MA. PMID: 29405697.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    34. Non-invasive detection of divergent metabolic signals in insulin deficiency vs. insulin resistance in vivo. Sci Rep. 2018 02 01; 8(1):2088. Morze CV, Allu PKR, Chang GY, Marco-Rius I, Milshteyn E, Wang ZJ, Ohliger MA, Gleason CE, Kurhanewicz J, Vigneron DB, Pearce D. PMID: 29391429.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    35. Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies. Magn Reson Med. 2018 09; 80(3):864-873. Park I, Larson PEZ, Gordon JW, Carvajal L, Chen HY, Bok R, Van Criekinge M, Ferrone M, Slater JB, Xu D, Kurhanewicz J, Vigneron DB, Chang S, Nelson SJ. PMID: 29322616.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    36. Direct assessment of renal mitochondrial redox state using hyperpolarized 13 C-acetoacetate. Magn Reson Med. 2018 04; 79(4):1862-1869. von Morze C, Ohliger MA, Marco-Rius I, Wilson DM, Flavell RR, Pearce D, Vigneron DB, Kurhanewicz J, Wang ZJ. PMID: 29314217.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    37. Sensitivity enhancement for detection of hyperpolarized 13 C MRI probes with 1 H spin coupling introduced by enzymatic transformation in vivo. Magn Reson Med. 2018 07; 80(1):36-41. von Morze C, Tropp J, Chen AP, Marco-Rius I, Van Criekinge M, Skloss TW, Mammoli D, Kurhanewicz J, Vigneron DB, Ohliger MA, Merritt ME. PMID: 29193287.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    38. Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standard. NMR Biomed. 2017 Dec; 30(12). Starobinets O, Simko JP, Kuchinsky K, Kornak J, Carroll PR, Greene KL, Kurhanewicz J, Noworolski SM. PMID: 28961382.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer. Radiol Bras. 2017 Sep-Oct; 50(5):299-307. Leapman MS, Wang ZJ, Behr SC, Kurhanewicz J, Zagoria RJ, Carroll PR, Westphalen AC. PMID: 29085163.
      View in: PubMed   Mentions:
    40. Unsaturation level decreased in bone marrow fat of postmenopausal women with low bone density using high resolution magic angle spinning (HRMAS) 1H NMR spectroscopy. Bone. 2017 Dec; 105:87-92. Li X, Shet K, Xu K, Rodríguez JP, Pino AM, Kurhanewicz J, Schwartz A, Rosen CJ. PMID: 28823880.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Androgen Ablation Therapy in Prostate Cancer. Eur Urol. 2017 12; 72(6):1028-1029. Aggarwal R, Vigneron DB, Kurhanewicz J. PMID: 28765011.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    42. Cancer recurrence monitoring using hyperpolarized [1-13C]pyruvate metabolic imaging in murine breast cancer model. Magn Reson Imaging. 2017 11; 43:105-109. Shin PJ, Zhu Z, Camarda R, Bok RA, Zhou AY, Kurhanewicz J, Goga A, Vigneron DB. PMID: 28716678.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    43. Hyperpolarized 13 C magnetic resonance evaluation of renal ischemia reperfusion injury in a murine model. NMR Biomed. 2017 Oct; 30(10). Baligand C, Qin H, True-Yasaki A, Gordon JW, von Morze C, Santos JD, Wilson DM, Raffai R, Cowley PM, Baker AJ, Kurhanewicz J, Lovett DH, Wang ZJ. PMID: 28708304.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    44. Dicarboxylic acids as pH sensors for hyperpolarized 13C magnetic resonance spectroscopic imaging. Analyst. 2017 May 02; 142(9):1429-1433. Korenchan DE, Taglang C, von Morze C, Blecha JE, Gordon JW, Sriram R, Larson PEZ, Vigneron DB, VanBrocklin HF, Kurhanewicz J, Wilson DM, Flavell RR. PMID: 28322385.
      View in: PubMed   Mentions: 3     Fields:    
    45. Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion. Cancer Res. 2017 06 15; 77(12):3207-3216. Chen HY, Larson PEZ, Bok RA, von Morze C, Sriram R, Delos Santos R, Delos Santos J, Gordon JW, Bahrami N, Ferrone M, Kurhanewicz J, Vigneron DB. PMID: 28428273.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    46. Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma. Sci Rep. 2017 03 22; 7:44792. Jalbert LE, Elkhaled A, Phillips JJ, Neill E, Williams A, Crane JC, Olson MP, Molinaro AM, Berger MS, Kurhanewicz J, Ronen SM, Chang SM, Nelson SJ. PMID: 28327577.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    47. Improved multiparametric MRI discrimination between low-risk prostate cancer and benign tissues in a small cohort of 5a-reductase inhibitor treated individuals as compared with an untreated cohort. NMR Biomed. 2017 May; 30(5). Starobinets O, Kurhanewicz J, Noworolski SM. PMID: 28164396.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Development of high resolution 3D hyperpolarized carbon-13 MR molecular imaging techniques. Magn Reson Imaging. 2017 05; 38:152-162. Milshteyn E, von Morze C, Reed GD, Shang H, Shin PJ, Zhu Z, Chen HY, Bok R, Goga A, Kurhanewicz J, Larson PE, Vigneron DB. PMID: 28077268.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    49. Monitoring acute metabolic changes in the liver and kidneys induced by fructose and glucose using hyperpolarized [2-13 C]dihydroxyacetone. Magn Reson Med. 2017 01; 77(1):65-73. Marco-Rius I, von Morze C, Sriram R, Cao P, Chang GY, Milshteyn E, Bok RA, Ohliger MA, Pearce D, Kurhanewicz J, Larson PE, Vigneron DB, Merritt M. PMID: 27859575.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    50. Spectrally selective three-dimensional dynamic balanced steady-state free precession for hyperpolarized C-13 metabolic imaging with spectrally selective radiofrequency pulses. Magn Reson Med. 2017 09; 78(3):963-975. Shang H, Sukumar S, von Morze C, Bok RA, Marco-Rius I, Kerr A, Reed GD, Milshteyn E, Ohliger MA, Kurhanewicz J, Larson PEZ, Pauly JM, Vigneron DB. PMID: 27770458.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    51. 18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 2017 Feb; 282(2):429-436. Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y. PMID: 27513849.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    52. Separation of extra- and intracellular metabolites using hyperpolarized (13)C diffusion weighted MR. J Magn Reson. 2016 09; 270:115-123. Koelsch BL, Sriram R, Keshari KR, Leon Swisher C, Van Criekinge M, Sukumar S, Vigneron DB, Wang ZJ, Larson PEZ, Kurhanewicz J. PMID: 27434780.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    53. Combining hyperpolarized 13 C MRI with a liver-specific gadolinium contrast agent for selective assessment of hepatocyte metabolism. Magn Reson Med. 2017 06; 77(6):2356-2363. Ohliger MA, von Morze C, Marco-Rius I, Gordon J, Larson PEZ, Bok R, Chen HY, Kurhanewicz J, Vigneron D. PMID: 27298073.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    54. Imaging Renal Urea Handling in Rats at Millimeter Resolution using Hyperpolarized Magnetic Resonance Relaxometry. Tomography. 2016 Jun; 2(2):125-135. Reed GD, von Morze C, Verkman AS, Koelsch BL, Chaumeil MM, Lustig M, Ronen SM, Bok RA, Sands JM, Larson PE, Wang ZJ, Larsen JH, Kurhanewicz J, Vigneron DB. PMID: 27570835.
      View in: PubMed   Mentions: 7     Fields:    
    55. Practical aspects of prostate MRI: hardware and software considerations, protocols, and patient preparation. Abdom Radiol (NY). 2016 05; 41(5):817-30. Starobinets O, Korn N, Iqbal S, Noworolski SM, Zagoria R, Kurhanewicz J, Westphalen AC. PMID: 27193785.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    56. Detection of localized changes in the metabolism of hyperpolarized gluconeogenic precursors 13 C-lactate and 13 C-pyruvate in kidney and liver. Magn Reson Med. 2017 04; 77(4):1429-1437. von Morze C, Chang GY, Larson PE, Shang H, Allu PK, Bok RA, Crane JC, Olson MP, Tan CT, Marco-Rius I, Nelson SJ, Kurhanewicz J, Pearce D, Vigneron DB. PMID: 27098724.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    57. Multiband spectral-spatial RF excitation for hyperpolarized [2-13 C]dihydroxyacetone 13 C-MR metabolism studies. Magn Reson Med. 2017 04; 77(4):1419-1428. Marco-Rius I, Cao P, von Morze C, Merritt M, Moreno KX, Chang GY, Ohliger MA, Pearce D, Kurhanewicz J, Larson PE, Vigneron DB. PMID: 27017966.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    58. Non-invasive differentiation of benign renal tumors from clear cell renal cell carcinomas using clinically translatable hyperpolarized 13C pyruvate magnetic resonance. Tomography. 2016 Mar; 2(1):35-42. Sriram R, Van Criekinge M, DeLos Santos J, Keshari KR, Wilson DM, Peehl D, Kurhanewicz J, Wang ZJ. PMID: 27227168.
      View in: PubMed   Mentions: 9     Fields:    
    59. Dynamic nuclear polarization of biocompatible (13)C-enriched carbonates for in vivo pH imaging. Chem Commun (Camb). 2016 Feb 18; 52(14):3030-3. Korenchan DE, Flavell RR, Baligand C, Sriram R, Neumann K, Sukumar S, VanBrocklin H, Vigneron DB, Wilson DM, Kurhanewicz J. PMID: 26792559.
      View in: PubMed   Mentions: 9     Fields:    
    60. Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography. Bioconjug Chem. 2016 Jan 20; 27(1):170-8. Flavell RR, Truillet C, Regan MK, Ganguly T, Blecha JE, Kurhanewicz J, VanBrocklin HF, Keshari KR, Chang CJ, Evans MJ, Wilson DM. PMID: 26649808.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    61. High-Resolution 3-T Endorectal Prostate MRI: A Multireader Study of Radiologist Preference and Perceived Interpretive Quality of 2D and 3D T2-Weighted Fast Spin-Echo MR Images. AJR Am J Roentgenol. 2016 Jan; 206(1):86-91. Westphalen AC, Noworolski SM, Harisinghani M, Jhaveri KS, Raman SS, Rosenkrantz AB, Wang ZJ, Zagoria RJ, Kurhanewicz J. PMID: 26491891.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    62. Application of Good's buffers to pH imaging using hyperpolarized (13)C MRI. Chem Commun (Camb). 2015 Sep 25; 51(74):14119-22. Flavell RR, von Morze C, Blecha JE, Korenchan DE, Van Criekinge M, Sriram R, Gordon JW, Chen HY, Subramaniam S, Bok RA, Wang ZJ, Vigneron DB, Larson PE, Kurhanewicz J, Wilson DM. PMID: 26257040.
      View in: PubMed   Mentions: 10     Fields:    Translation:Cells
    63. Real-time measurement of hyperpolarized lactate production and efflux as a biomarker of tumor aggressiveness in an MR compatible 3D cell culture bioreactor. NMR Biomed. 2015 Sep; 28(9):1141-9. Sriram R, Van Criekinge M, Hansen A, Wang ZJ, Vigneron DB, Wilson DM, Keshari KR, Kurhanewicz J. PMID: 26202449.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    64. Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor. Prostate. 2015 Oct; 75(14):1601-9. Keshari KR, Wilson DM, Van Criekinge M, Sriram R, Koelsch BL, Wang ZJ, VanBrocklin HF, Peehl DM, O'Brien T, Sampath D, Carano RA, Kurhanewicz J. PMID: 26177608.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    65. Dynamic UltraFast 2D EXchange SpectroscopY (UF-EXSY) of hyperpolarized substrates. J Magn Reson. 2015 Aug; 257:102-9. Leon Swisher C, Koelsch B, Sukumar S, Sriram R, Santos RD, Wang ZJ, Kurhanewicz J, Vigneron D, Larson P. PMID: 26117655.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    66. Hyperpolarized [(13)C]ketobutyrate, a molecular analog of pyruvate with modified specificity for LDH isoforms. Magn Reson Med. 2016 May; 75(5):1894-900. von Morze C, Bok RA, Ohliger MA, Zhu Z, Vigneron DB, Kurhanewicz J. PMID: 26059096.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    67. Correlating high-resolution magic angle spinning NMR spectroscopy and gene analysis in osteoarthritic cartilage. NMR Biomed. 2015 May; 28(5):523-8. Tufts L, Shet Vishnudas K, Fu E, Kurhanewicz J, Ries M, Alliston T, Li X. PMID: 25761416.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. A Domain Constrained Deformable (DoCD) Model for Co-registration of Pre- and Post-Radiated Prostate MRI. Neurocomputing. 2014 Nov 20; 114:3-12. Toth R, Traughber B, Ellis R, Kurhanewicz J, Madabhushi A. PMID: 25267873.
      View in: PubMed   Mentions:
    69. Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance. Abdom Imaging. 2014 Oct; 39(5):1027-35. Flavell RR, Westphalen AC, Liang C, Sotto CC, Noworolski SM, Vigneron DB, Wang ZJ, Kurhanewicz J. PMID: 24740760.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    70. Rapid in vivo apparent diffusion coefficient mapping of hyperpolarized (13) C metabolites. Magn Reson Med. 2015 Sep; 74(3):622-633. Koelsch BL, Reed GD, Keshari KR, Chaumeil MM, Bok R, Ronen SM, Vigneron DB, Kurhanewicz J, Larson PEZ. PMID: 25213126.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    71. Reduced-FOV excitation decreases susceptibility artifact in diffusion-weighted MRI with endorectal coil for prostate cancer detection. Magn Reson Imaging. 2015 Jan; 33(1):56-62. Korn N, Kurhanewicz J, Banerjee S, Starobinets O, Saritas E, Noworolski S. PMID: 25200645.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    72. Noninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized 13C dehydroascorbate magnetic resonance. Diabetes. 2015 Feb; 64(2):344-52. Keshari KR, Wilson DM, Sai V, Bok R, Jen KY, Larson P, Van Criekinge M, Kurhanewicz J, Wang ZJ. PMID: 25187363.
      View in: PubMed   Mentions: 20     Fields:    Translation:Animals
    73. Hyperpolarized 13C MR for molecular imaging of prostate cancer. J Nucl Med. 2014 Oct; 55(10):1567-72. Wilson DM, Kurhanewicz J. PMID: 25168625.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    74. OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proc Natl Acad Sci U S A. 2014 Jul 08; 111(27):9983-8. Chen L, Shu Y, Liang X, Chen EC, Yee SW, Zur AA, Li S, Xu L, Keshari KR, Lin MJ, Chien HC, Zhang Y, Morrissey KM, Liu J, Ostrem J, Younger NS, Kurhanewicz J, Shokat KM, Ashrafi K, Giacomini KM. PMID: 24961373.
      View in: PubMed   Mentions: 54     Fields:    Translation:AnimalsCells
    75. Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array. Med Phys. 2014 Mar; 41(3):033301. Salgaonkar VA, Prakash P, Rieke V, Ozhinsky E, Plata J, Kurhanewicz J, Hsu IC, Diederich CJ. PMID: 24593742.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    76. Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: quantitative analysis of imaging contour compared to whole-mount histopathology. Radiother Oncol. 2014 Feb; 110(2):303-8. Anwar M, Westphalen AC, Jung AJ, Noworolski SM, Simko JP, Kurhanewicz J, Roach M, Carroll PR, Coakley FV. PMID: 24444524.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    77. The changing role of imaging in clinical care. Nat Rev Urol. 2014 Feb; 11(2):75-7. Aggarwal R, Kurhanewicz J. PMID: 24418808.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    78. Simultaneous multiagent hyperpolarized (13)C perfusion imaging. Magn Reson Med. 2014 Dec; 72(6):1599-609. von Morze C, Bok RA, Reed GD, Ardenkjaer-Larsen JH, Kurhanewicz J, Vigneron DB. PMID: 24382698.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    79. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel. BJU Int. 2014 Feb; 113(2):218-27. Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M. PMID: 24215670.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    80. Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy. Radiother Oncol. 2013 Nov; 109(2):246-50. Crehange G, Krishnamurthy D, Cunha JA, Pickett B, Kurhanewicz J, Hsu IC, Gottschalk AR, Shinohara K, Roach M, Pouliot J. PMID: 24231238.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    81. Clinical utility of endorectal MRI-guided prostate biopsy: preliminary experience. J Magn Reson Imaging. 2014 Aug; 40(2):314-23. Jung AJ, Westphalen AC, Kurhanewicz J, Wang ZJ, Carroll PR, Simko JP, Coakley FV. PMID: 24924999.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    82. High resolution (13)C MRI with hyperpolarized urea: in vivo T(2) mapping and (15)N labeling effects. IEEE Trans Med Imaging. 2014 Feb; 33(2):362-71. Reed GD, von Morze C, Bok R, Koelsch BL, Van Criekinge M, Smith KJ, Larson PE, Kurhanewicz J, Vigneron DB. PMID: 24235273.
      View in: PubMed   Mentions: 25     Fields:    Translation:Animals
    83. Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded prostates. J Magn Reson Imaging. 2014 May; 39(5):1223-9. Starobinets O, Guo R, Simko JP, Kuchinsky K, Kurhanewicz J, Carroll PR, Greene KL, Noworolski SM. PMID: 24136783.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    84. Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate. Sci Transl Med. 2013 Aug 14; 5(198):198ra108. Nelson SJ, Kurhanewicz J, Vigneron DB, Larson PE, Harzstark AL, Ferrone M, van Criekinge M, Chang JW, Bok R, Park I, Reed G, Carvajal L, Small EJ, Munster P, Weinberg VK, Ardenkjaer-Larsen JH, Chen AP, Hurd RE, Odegardstuen LI, Robb FJ, Tropp J, Murray JA. PMID: 23946197.
      View in: PubMed   Mentions: 311     Fields:    Translation:Humans
    85. The role of metabolic imaging in radiation therapy of prostate cancer. NMR Biomed. 2014 Jan; 27(1):100-11. Zhang VY, Westphalen A, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 23940096.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    86. Endorectal MRI and MR spectroscopic imaging of prostate cancer: developing selection criteria for MR-guided focal therapy. J Magn Reson Imaging. 2014 Mar; 39(3):519-25. Chang ST, Westphalen AC, Jha P, Jung AJ, Carroll PR, Kurhanewicz J, Coakley FV. PMID: 23681669.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    87. Hyperpolarized [1-13C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with 18F-FDG PET. J Nucl Med. 2013 Jun; 54(6):922-8. Keshari KR, Sai V, Wang ZJ, Vanbrocklin HF, Kurhanewicz J, Wilson DM. PMID: 23575993.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    88. Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor. Prostate. 2013 Aug; 73(11):1171-81. Keshari KR, Sriram R, Van Criekinge M, Wilson DM, Wang ZJ, Vigneron DB, Peehl DM, Kurhanewicz J. PMID: 23532911.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    89. Diffusion MR of hyperpolarized 13C molecules in solution. Analyst. 2013 Feb 21; 138(4):1011-4. Koelsch BL, Keshari KR, Peeters TH, Larson PE, Wilson DM, Kurhanewicz J. PMID: 23304699.
      View in: PubMed   Mentions: 12     Fields:    
    90. Quantitative measurement of cancer metabolism using stimulated echo hyperpolarized carbon-13 MRS. Magn Reson Med. 2014 Jan; 71(1):1-11. Swisher CL, Larson PE, Kruttwig K, Kerr AB, Hu S, Bok RA, Goga A, Pauly JM, Nelson SJ, Kurhanewicz J, Vigneron DB. PMID: 23412881.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    91. Combined parallel and partial fourier MR reconstruction for accelerated 8-channel hyperpolarized carbon-13 in vivo magnetic resonance Spectroscopic imaging (MRSI). J Magn Reson Imaging. 2013 Sep; 38(3):701-13. Ohliger MA, Larson PE, Bok RA, Shin P, Hu S, Tropp J, Robb F, Carvajal L, Nelson SJ, Kurhanewicz J, Vigneron DB. PMID: 23293097.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    92. Perfusion and diffusion sensitive 13C stimulated-echo MRSI for metabolic imaging of cancer. Magn Reson Imaging. 2013 Jun; 31(5):635-42. Larson PE, Hurd RE, Kerr AB, Pauly JM, Bok RA, Kurhanewicz J, Vigneron DB. PMID: 23260391.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    93. Imaging a functional tumorigenic biomarker in the transformed epithelium. Proc Natl Acad Sci U S A. 2013 Jan 02; 110(1):93-8. LeBeau AM, Lee M, Murphy ST, Hann BC, Warren RS, Delos Santos R, Kurhanewicz J, Hanash SM, VanBrocklin HF, Craik CS. PMID: 23248318.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    94. Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRS. Med Image Anal. 2013 Feb; 17(2):219-35. Tiwari P, Kurhanewicz J, Madabhushi A. PMID: 23294985.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    95. Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomas. Cancer Res. 2013 Jan 15; 73(2):529-38. Keshari KR, Sriram R, Koelsch BL, Van Criekinge M, Wilson DM, Kurhanewicz J, Wang ZJ. PMID: 23204238.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    96. Progress in prostate cancer imaging. Urol Oncol. 2012 Nov-Dec; 30(6):938-9. Gulley JL, Emberton M, Kurhanewicz J, Choyke P. PMID: 23218070.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    97. Rapid sequential injections of hyperpolarized [1-¹³C]pyruvate in vivo using a sub-kelvin, multi-sample DNP polarizer. Magn Reson Imaging. 2013 May; 31(4):490-6. Hu S, Larson PE, Vancriekinge M, Leach AM, Park I, Leon C, Zhou J, Shin PJ, Reed G, Keselman P, von Morze C, Yoshihara H, Bok RA, Nelson SJ, Kurhanewicz J, Vigneron DB. PMID: 23107275.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    98. Frequency-specific SSFP for hyperpolarized ¹³C metabolic imaging at 14.1 T. Magn Reson Imaging. 2013 Feb; 31(2):163-70. von Morze C, Sukumar S, Reed GD, Larson PE, Bok RA, Kurhanewicz J, Vigneron DB. PMID: 22898680.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    99. Use of hyperpolarized [1-13C]pyruvate and [2-13C]pyruvate to probe the effects of the anticancer agent dichloroacetate on mitochondrial metabolism in vivo in the normal rat. Magn Reson Imaging. 2012 Dec; 30(10):1367-72. Hu S, Yoshihara HA, Bok R, Zhou J, Zhu M, Kurhanewicz J, Vigneron DB. PMID: 22819176.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    100. Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm. Cancer Treat Rev. 2012 Dec; 38(8):956-67. Créhange G, Chen CP, Hsu CC, Kased N, Coakley FV, Kurhanewicz J, Roach M. PMID: 22703831.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    101. Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound. Clin Imaging. 2012 Sep-Oct; 36(5):547-52. Jung AJ, Coakley FV, Shinohara K, Carroll PR, Kurhanewicz J, Cowan JE, Westphalen AC. PMID: 22920360.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    102. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):370-7. Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, Weinberg V, Gottschalk AR, Kurhanewicz J, Shinohara K, Roach M. PMID: 22672747.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    103. Generating contrast in hyperpolarized 13C MRI using ligand-receptor interactions. Analyst. 2012 Aug 07; 137(15):3427-9. Keshari KR, Kurhanewicz J, Macdonald JM, Wilson DM. PMID: 22655289.
      View in: PubMed   Mentions: 6     Fields:    
    104. Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer. J Magn Reson Imaging. 2012 Aug; 36(2):430-7. Westphalen AC, Reed GD, Vinh PP, Sotto C, Vigneron DB, Kurhanewicz J. PMID: 22535708.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    105. Monitoring urea transport in rat kidney in vivo using hyperpolarized ¹³C magnetic resonance imaging. Am J Physiol Renal Physiol. 2012 Jun 15; 302(12):F1658-62. von Morze C, Bok RA, Sands JM, Kurhanewicz J, Vigneron DB. PMID: 22492940.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    106. A method for simultaneous echo planar imaging of hyperpolarized ¹³C pyruvate and ¹³C lactate. J Magn Reson. 2012 Apr; 217:41-7. Reed GD, Larson PE, Morze Cv, Bok R, Lustig M, Kerr AB, Pauly JM, Kurhanewicz J, Vigneron DB. PMID: 22405760.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    107. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):e787-93. Arrayeh E, Westphalen AC, Kurhanewicz J, Roach M, Jung AJ, Carroll PR, Coakley FV. PMID: 22331003.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    108. Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model. Cancer Biol Ther. 2011 Dec 15; 12(12):1078-84. Costello LC, Franklin RB, Zou J, Feng P, Bok R, Swanson MG, Kurhanewicz J. PMID: 22156800.
      View in: PubMed   Mentions: 21     Fields:    Translation:Animals
    109. Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced disease. AJR Am J Roentgenol. 2011 Dec; 197(6):1369-74. Muglia VF, Westphalen AC, Wang ZJ, Kurhanewicz J, Carroll PR, Coakley FV. PMID: 22109291.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    110. Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer. BJU Int. 2012 Jun; 109(11):1636-47. Ahmed HU, Akin O, Coleman JA, Crane S, Emberton M, Goldenberg L, Hricak H, Kattan MW, Kurhanewicz J, Moore CM, Parker C, Polascik TJ, Scardino P, van As N, Villers A. PMID: 22077593.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    111. Hyperpolarized 13C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging. Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46):18606-11. Keshari KR, Kurhanewicz J, Bok R, Larson PE, Vigneron DB, Wilson DM. PMID: 22042839.
      View in: PubMed   Mentions: 63     Fields:    Translation:AnimalsCells
    112. Generating super stimulated-echoes in MRI and their application to hyperpolarized C-13 diffusion metabolic imaging. IEEE Trans Med Imaging. 2012 Feb; 31(2):265-75. Larson PE, Kerr AB, Reed GD, Hurd RE, Kurhanewicz J, Pauly JM, Vigneron DB. PMID: 22027366.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    113. Diagnostic tools and imaging methods in intervertebral disk degeneration. Orthop Clin North Am. 2011 Oct; 42(4):501-11, viii. Majumdar S, Link TM, Steinbach LS, Hu S, Kurhanewicz J. PMID: 21944587.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    114. Multimodal wavelet embedding representation for data combination (MaWERiC): integrating magnetic resonance imaging and spectroscopy for prostate cancer detection. NMR Biomed. 2012 Apr; 25(4):607-19. Tiwari P, Viswanath S, Kurhanewicz J, Sridhar A, Madabhushi A. PMID: 21960175.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    115. Prostate cancer: prediction of biochemical failure after external-beam radiation therapy--Kattan nomogram and endorectal MR imaging estimation of tumor volume. Radiology. 2011 Nov; 261(2):477-86. Westphalen AC, Koff WJ, Coakley FV, Muglia VF, Neuhaus JM, Marcus RT, Kurhanewicz J, Smith-Bindman R. PMID: 21873255.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    116. In vivo measurement of normal rat intracellular pyruvate and lactate levels after injection of hyperpolarized [1-(13)C]alanine. Magn Reson Imaging. 2011 Oct; 29(8):1035-40. Hu S, Zhu M, Yoshihara HA, Wilson DM, Keshari KR, Shin P, Reed G, von Morze C, Bok R, Larson PE, Kurhanewicz J, Vigneron DB. PMID: 21855243.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    117. High-resolution magic angle spinning NMR spectroscopy of human osteoarthritic cartilage. NMR Biomed. 2012 Apr; 25(4):538-44. Shet K, Siddiqui SM, Yoshihara H, Kurhanewicz J, Ries M, Li X. PMID: 21850648.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    118. 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. Cell Metab. 2011 Jul 06; 14(1):131-42. Hu S, Balakrishnan A, Bok RA, Anderton B, Larson PE, Nelson SJ, Kurhanewicz J, Vigneron DB, Goga A. PMID: 21723511.
      View in: PubMed   Mentions: 83     Fields:    Translation:AnimalsCells
    119. Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment. NMR Biomed. 2011 Jul; 24(6):691-9. Keshari KR, Tsachres H, Iman R, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 21793074.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    120. Magnetic resonance spectroscopic imaging of benign prostatic tissue: findings at 3.0 T compared to 1.5 T-initial experience. Clin Imaging. 2011 Jul-Aug; 35(4):288-93. Chitkara M, Westphalen A, Kurhanewicz J, Qayyum A, Poder L, Reed G, Coakley FV. PMID: 21724122.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    121. Endorectal MRI after radiation therapy: questioning the sextant analysis. J Magn Reson Imaging. 2011 May; 33(5):1086-90. Kumbhani SR, Coakley FV, McCulloch CE, Wang ZJ, Kurhanewicz J, Roach M, Westphalen AC. PMID: 21509865.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    122. Interactive, multi-modality image registrations for combined MRI/MRSI-planned HDR prostate brachytherapy. J Contemp Brachytherapy. 2011 Mar 31; 3(1):26-31. Reed G, Cunha JA, Noworolski S, Kurhanewicz J, Vigneron D, Hsu IC, Pouliot J. PMID: 23606866.
      View in: PubMed   Mentions:
    123. A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer. BJU Int. 2011 Oct; 108(8 Pt 2):E164-70. Chung HT, Noworolski SM, Kurhanewicz J, Weinberg V, Roach Iii M. PMID: 21435153.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    124. A hydrogen peroxide-responsive hyperpolarized 13C MRI contrast agent. J Am Chem Soc. 2011 Mar 23; 133(11):3776-9. Lippert AR, Keshari KR, Kurhanewicz J, Chang CJ. PMID: 21366297.
      View in: PubMed   Mentions: 25     Fields:    
    125. CADOnc©: An Integrated Toolkit For Evaluating Radiation Therapy Related Changes In The Prostate Using Multiparametric MRI. Proc IEEE Int Symp Biomed Imaging. 2011 Mar; 2011:2095-2098. Viswanath S, Tiwari P, Chappelow J, Toth R, Kurhanewicz J, Madabhushi A. PMID: 25360226.
      View in: PubMed   Mentions:
    126. Imaging of blood flow using hyperpolarized [(13)C]urea in preclinical cancer models. J Magn Reson Imaging. 2011 Mar; 33(3):692-7. von Morze C, Larson PE, Hu S, Keshari K, Wilson DM, Ardenkjaer-Larsen JH, Goga A, Bok R, Kurhanewicz J, Vigneron DB. PMID: 21563254.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    127. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia. 2011 Feb; 13(2):81-97. Kurhanewicz J, Vigneron DB, Brindle K, Chekmenev EY, Comment A, Cunningham CH, Deberardinis RJ, Green GG, Leach MO, Rajan SS, Rizi RR, Ross BD, Warren WS, Malloy CR. PMID: 21403835.
      View in: PubMed   Mentions: 265     Fields:    Translation:Humans
    128. A magnetic resonance spectroscopy driven initialization scheme for active shape model based prostate segmentation. Med Image Anal. 2011 Apr; 15(2):214-25. Toth R, Tiwari P, Rosen M, Reed G, Kurhanewicz J, Kalyanpur A, Pungavkar S, Madabhushi A. PMID: 21195016.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    129. Fast dynamic 3D MR spectroscopic imaging with compressed sensing and multiband excitation pulses for hyperpolarized 13C studies. Magn Reson Med. 2011 Mar; 65(3):610-9. Larson PE, Hu S, Lustig M, Kerr AB, Nelson SJ, Kurhanewicz J, Pauly JM, Vigneron DB. PMID: 20939089.
      View in: PubMed   Mentions: 55     Fields:    Translation:Animals
    130. Semi-parametric time-domain quantification of HR-MAS data from prostate tissue. NMR Biomed. 2010 Dec; 23(10):1146-57. Ratiney H, Albers MJ, Rabeson H, Kurhanewicz J. PMID: 20842756.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    131. Post-processing correction of the endorectal coil reception effects in MR spectroscopic imaging of the prostate. J Magn Reson Imaging. 2010 Sep; 32(3):654-62. Noworolski SM, Reed GD, Kurhanewicz J, Vigneron DB. PMID: 20815064.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    132. Toward adaptive stereotactic robotic brachytherapy for prostate cancer: demonstration of an adaptive workflow incorporating inverse planning and an MR stealth robot. Minim Invasive Ther Allied Technol. 2010 Aug; 19(4):189-202. Cunha JA, Hsu IC, Pouliot J, Roach Iii M, Shinohara K, Kurhanewicz J, Reed G, Stoianovici D. PMID: 20642386.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    133. Calculation of gestational age in late second and third trimesters by ex vivo magnetic resonance spectroscopy of amniotic fluid. Am J Obstet Gynecol. 2010 Jul; 203(1):76.e1-76.e10. Cohn BR, Fukuchi EY, Joe BN, Swanson MG, Kurhanewicz J, Yu J, Caughey AB. PMID: 20435286.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    134. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection. Radiology. 2010 Aug; 256(2):485-92. Westphalen AC, Coakley FV, Roach M, McCulloch CE, Kurhanewicz J. PMID: 20551184.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    135. Prostate MRI and 3D MR spectroscopy: how we do it. AJR Am J Roentgenol. 2010 Jun; 194(6):1414-26. Verma S, Rajesh A, Fütterer JJ, Turkbey B, Scheenen TW, Pang Y, Choyke PL, Kurhanewicz J. PMID: 20489079.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    136. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology. 2010 Jul; 256(1):176-83. Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, Carroll PR. PMID: 20505068.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    137. Metabolic imaging in the anesthetized rat brain using hyperpolarized [1-13C] pyruvate and [1-13C] ethyl pyruvate. Magn Reson Med. 2010 May; 63(5):1137-43. Hurd RE, Yen YF, Mayer D, Chen A, Wilson D, Kohler S, Bok R, Vigneron D, Kurhanewicz J, Tropp J, Spielman D, Pfefferbaum A. PMID: 20432284.
      View in: PubMed   Mentions: 45     Fields:    Translation:Animals
    138. Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. J Magn Reson. 2010 Jul; 205(1):141-7. Wilson DM, Keshari KR, Larson PE, Chen AP, Hu S, Van Criekinge M, Bok R, Nelson SJ, Macdonald JM, Vigneron DB, Kurhanewicz J. PMID: 20478721.
      View in: PubMed   Mentions: 66     Fields:    Translation:Animals
    139. Investigation of tumor hyperpolarized [1-13C]-pyruvate dynamics using time-resolved multiband RF excitation echo-planar MRSI. Magn Reson Med. 2010 Mar; 63(3):582-91. Larson PE, Bok R, Kerr AB, Lustig M, Hu S, Chen AP, Nelson SJ, Pauly JM, Kurhanewicz J, Vigneron DB. PMID: 20187172.
      View in: PubMed   Mentions: 38     Fields:    Translation:Animals
    140. Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. Cancer Res. 2010 Feb 15; 70(4):1296-305. Ward CS, Venkatesh HS, Chaumeil MM, Brandes AH, Vancriekinge M, Dafni H, Sukumar S, Nelson SJ, Vigneron DB, Kurhanewicz J, James CD, Haas-Kogan DA, Ronen SM. PMID: 20145128.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansAnimalsCells
    141. A novel application of 1H magnetic resonance spectroscopy: non-invasive identification of spermatogenesis in men with non-obstructive azoospermia. Hum Reprod. 2010 Apr; 25(4):847-52. Aaronson DS, Iman R, Walsh TJ, Kurhanewicz J, Turek PJ. PMID: 20124393.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    142. Hyperpolarized (13)C spectroscopy and an NMR-compatible bioreactor system for the investigation of real-time cellular metabolism. Magn Reson Med. 2010 Feb; 63(2):322-9. Keshari KR, Kurhanewicz J, Jeffries RE, Wilson DM, Dewar BJ, Van Criekinge M, Zierhut M, Vigneron DB, Macdonald JM. PMID: 20099325.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    143. 3D compressed sensing for highly accelerated hyperpolarized (13)C MRSI with in vivo applications to transgenic mouse models of cancer. Magn Reson Med. 2010 Feb; 63(2):312-21. Hu S, Lustig M, Balakrishnan A, Larson PE, Bok R, Kurhanewicz J, Nelson SJ, Goga A, Pauly JM, Vigneron DB. PMID: 20017160.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimals
    144. Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro Oncol. 2010 Feb; 12(2):133-44. Park I, Larson PE, Zierhut ML, Hu S, Bok R, Ozawa T, Kurhanewicz J, Vigneron DB, Vandenberg SR, James CD, Nelson SJ. PMID: 20150380.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimals
    145. Semi supervised multi kernel (SeSMiK) graph embedding: identifying aggressive prostate cancer via magnetic resonance imaging and spectroscopy. Med Image Comput Comput Assist Interv. 2010; 13(Pt 3):666-73. Tiwari P, Kurhanewicz J, Rosen M, Madabhushi A. PMID: 20879458.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    146. Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. NMR Biomed. 2010 May; 23(4):391-8. Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Santos RD, Federman S, Shinohara K, Carroll PR, Haqq CM, Swanson MG. PMID: 20033906.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    147. Hyperpolarized [2-13C]-fructose: a hemiketal DNP substrate for in vivo metabolic imaging. J Am Chem Soc. 2009 Dec 09; 131(48):17591-6. Keshari KR, Wilson DM, Chen AP, Bok R, Larson PE, Hu S, Van Criekinge M, Macdonald JM, Vigneron DB, Kurhanewicz J. PMID: 19860409.
      View in: PubMed   Mentions: 38     Fields:    Translation:Animals
    148. Methods for metabolic evaluation of prostate cancer cells using proton and (13)C HR-MAS spectroscopy and [3-(13)C] pyruvate as a metabolic substrate. Magn Reson Med. 2009 Nov; 62(5):1091-8. Levin YS, Albers MJ, Butler TN, Spielman D, Peehl DM, Kurhanewicz J. PMID: 19780158.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    149. Assessment of intervertebral disc degeneration with magnetic resonance single-voxel spectroscopy. Magn Reson Med. 2009 Nov; 62(5):1140-6. Zuo J, Saadat E, Romero A, Loo K, Li X, Link TM, Kurhanewicz J, Majumdar S. PMID: 19780173.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    150. Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. J Magn Reson. 2010 Jan; 202(1):85-92. Zierhut ML, Yen YF, Chen AP, Bok R, Albers MJ, Zhang V, Tropp J, Park I, Vigneron DB, Kurhanewicz J, Hurd RE, Nelson SJ. PMID: 19884027.
      View in: PubMed   Mentions: 64     Fields:    Translation:Animals
    151. Quantitative metabolic profiles of 2nd and 3rd trimester human amniotic fluid using (1)H HR-MAS spectroscopy. MAGMA. 2009 Dec; 22(6):343-52. Cohn BR, Joe BN, Zhao S, Kornak J, Zhang VY, Iman R, Kurhanewicz J, Vahidi K, Yu J, Caughey AB, Swanson MG. PMID: 19779747.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    152. Mucinous adenocarcinoma of the prostate: MRI and MR spectroscopy features. AJR Am J Roentgenol. 2009 Sep; 193(3):W238-43. Westphalen AC, Coakley FV, Kurhanewicz J, Reed G, Wang ZJ, Simko JP. PMID: 19696265.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    153. Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer. Magn Reson Imaging. 2010 Feb; 28(2):153-62. Lupo JM, Chen AP, Zierhut ML, Bok RA, Cunningham CH, Kurhanewicz J, Vigneron DB, Nelson SJ. PMID: 19695815.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    154. Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C-pyruvate. Magn Reson Med. 2009 Jul; 62(1):1-10. Yen YF, Kohler SJ, Chen AP, Tropp J, Bok R, Wolber J, Albers MJ, Gram KA, Zierhut ML, Park I, Zhang V, Hu S, Nelson SJ, Vigneron DB, Kurhanewicz J, Dirven HA, Hurd RE. PMID: 19319902.
      View in: PubMed   Mentions: 42     Fields:    Translation:Animals
    155. In vivo carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate. Mol Imaging Biol. 2009 Nov-Dec; 11(6):399-407. Hu S, Chen AP, Zierhut ML, Bok R, Yen YF, Schroeder MA, Hurd RE, Nelson SJ, Kurhanewicz J, Vigneron DB. PMID: 19424761.
      View in: PubMed   Mentions: 26     Fields:    Translation:Animals
    156. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology. 2009 Apr; 251(1):122-33. Weinreb JC, Blume JD, Coakley FV, Wheeler TM, Cormack JB, Sotto CK, Cho H, Kawashima A, Tempany-Afdhal CM, Macura KJ, Rosen M, Gerst SR, Kurhanewicz J. PMID: 19332850.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    157. Generation of hyperpolarized substrates by secondary labeling with [1,1-13C] acetic anhydride. Proc Natl Acad Sci U S A. 2009 Apr 07; 106(14):5503-7. Wilson DM, Hurd RE, Keshari K, Van Criekinge M, Chen AP, Nelson SJ, Vigneron DB, Kurhanewicz J. PMID: 19276112.
      View in: PubMed   Mentions: 20     Fields:    
    158. T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy. Int Braz J Urol. 2009 Mar-Apr; 35(2):171-80; discussion 181-2. Westphalen AC, Kurhanewicz J, Cunha RM, Hsu IC, Kornak J, Zhao S, Coakley FV. PMID: 19409121.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    159. Evaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue. Magn Reson Med. 2009 Mar; 61(3):525-32. Albers MJ, Butler TN, Rahwa I, Bao N, Keshari KR, Swanson MG, Kurhanewicz J. PMID: 19235261.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    160. Spectral embedding based probabilistic boosting tree (ScEPTre): classifying high dimensional heterogeneous biomedical data. Med Image Comput Comput Assist Interv. 2009; 12(Pt 2):844-51. Tiwari P, Rosen M, Reed G, Kurhanewicz J, Madabhushi A. PMID: 20426190.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    161. In vivo hyperpolarized 13C MR spectroscopic imaging with 1H decoupling. J Magn Reson. 2009 Mar; 197(1):100-6. Chen AP, Tropp J, Hurd RE, Van Criekinge M, Carvajal LG, Xu D, Kurhanewicz J, Vigneron DB. PMID: 19112035.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    162. (1)H HR-MAS spectroscopy for quantitative measurement of choline concentration in amniotic fluid as a marker of fetal lung maturity: inter- and intraobserver reproducibility study. J Magn Reson Imaging. 2008 Dec; 28(6):1540-5. Joe BN, Vahidi K, Zektzer A, Chen MH, Clifton MS, Butler T, Keshari K, Kurhanewicz J, Coakley F, Swanson MG. PMID: 19025962.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    163. Advances in MR spectroscopy of the prostate. Magn Reson Imaging Clin N Am. 2008 Nov; 16(4):697-710, ix-x. Kurhanewicz J, Vigneron DB. PMID: 18926432.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    164. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol. 2009 Mar; 55(3):575-90. Umbehr M, Bachmann LM, Held U, Kessler TM, Sulser T, Weishaupt D, Kurhanewicz J, Steurer J. PMID: 18952365.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    165. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res. 2008 Oct 15; 68(20):8607-15. Albers MJ, Bok R, Chen AP, Cunningham CH, Zierhut ML, Zhang VY, Kohler SJ, Tropp J, Hurd RE, Yen YF, Nelson SJ, Vigneron DB, Kurhanewicz J. PMID: 18922937.
      View in: PubMed   Mentions: 199     Fields:    Translation:Animals
    166. In vivo (1)H magnetic resonance spectroscopy of amniotic fluid and fetal lung at 1.5 T: technical challenges. J Magn Reson Imaging. 2008 Oct; 28(4):1033-8. Kim DH, Vahidi K, Caughey AB, Coakley FV, Vigneron DB, Kurhanewicz J, Mow B, Joe BN. PMID: 18821604.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    167. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med. 2008 Sep; 60(3):510-6. Tessem MB, Swanson MG, Keshari KR, Albers MJ, Joun D, Tabatabai ZL, Simko JP, Shinohara K, Nelson SJ, Vigneron DB, Gribbestad IS, Kurhanewicz J. PMID: 18727052.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    168. Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Mar 01; 73(3):665-71. Joseph T, McKenna DA, Westphalen AC, Coakley FV, Zhao S, Lu Y, Hsu IC, Roach M, Kurhanewicz J. PMID: 18760545.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    169. Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn Reson Med. 2008 Jul; 60(1):33-40. Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll PR, Zektzer AS, Kurhanewicz J. PMID: 18581409.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    170. Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imaging. J Magn Reson. 2008 Sep; 194(1):121-7. Larson PE, Kerr AB, Chen AP, Lustig MS, Zierhut ML, Hu S, Cunningham CH, Pauly JM, Kurhanewicz J, Vigneron DB. PMID: 18619875.
      View in: PubMed   Mentions: 47     Fields:    Translation:AnimalsCells
    171. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging. 2008 Oct; 26(8):1071-80. Noworolski SM, Vigneron DB, Chen AP, Kurhanewicz J. PMID: 18508221.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    172. Feasibility of using hyperpolarized [1-13C]lactate as a substrate for in vivo metabolic 13C MRSI studies. Magn Reson Imaging. 2008 Jul; 26(6):721-6. Chen AP, Kurhanewicz J, Bok R, Xu D, Joun D, Zhang V, Nelson SJ, Hurd RE, Vigneron DB. PMID: 18479878.
      View in: PubMed   Mentions: 41     Fields:    Translation:Animals
    173. A clinical comparison of rigid and inflatable endorectal-coil probes for MRI and 3D MR spectroscopic imaging (MRSI) of the prostate. J Magn Reson Imaging. 2008 May; 27(5):1077-82. Noworolski SM, Crane JC, Vigneron DB, Kurhanewicz J. PMID: 18407539.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    174. Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology. 2008 May; 247(2):444-50. Cabrera AR, Coakley FV, Westphalen AC, Lu Y, Zhao S, Shinohara K, Carroll PR, Kurhanewicz J. PMID: 18430877.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    175. Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer. J Endourol. 2008 Apr; 22(4):789-94. Westphalen AC, McKenna DA, Kurhanewicz J, Coakley FV. PMID: 18366322.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    176. Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J Magn Reson. 2008 Jul; 193(1):139-46. Cunningham CH, Chen AP, Lustig M, Hargreaves BA, Lupo J, Xu D, Kurhanewicz J, Hurd RE, Pauly JM, Nelson SJ, Vigneron DB. PMID: 18424203.
      View in: PubMed   Mentions: 40     Fields:    Translation:Animals
    177. Compressed sensing for resolution enhancement of hyperpolarized 13C flyback 3D-MRSI. J Magn Reson. 2008 Jun; 192(2):258-64. Hu S, Lustig M, Chen AP, Crane J, Kerr A, Kelley DA, Hurd R, Kurhanewicz J, Nelson SJ, Pauly JM, Vigneron DB. PMID: 18367420.
      View in: PubMed   Mentions: 54     Fields:    Translation:Animals
    178. Current and potential applications of clinical 13C MR spectroscopy. J Nucl Med. 2008 Mar; 49(3):341-4. Kurhanewicz J, Bok R, Nelson SJ, Vigneron DB. PMID: 18322118.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    179. Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI. Radiother Oncol. 2008 Jul; 88(1):148-55. Kim Y, Hsu IC, Lessard E, Kurhanewicz J, Noworolski SM, Pouliot J. PMID: 18083260.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    180. Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experience. Radiology. 2008 Apr; 247(1):141-6. McKenna DA, Coakley FV, Westphalen AC, Zhao S, Lu Y, Webb EM, Pickett B, Roach M, Kurhanewicz J. PMID: 18258811.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    181. Lactic acid and proteoglycans as metabolic markers for discogenic back pain. Spine (Phila Pa 1976). 2008 Feb 01; 33(3):312-7. Keshari KR, Lotz JC, Link TM, Hu S, Majumdar S, Kurhanewicz J. PMID: 18303465.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    182. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol. 2008 Jan; 18(1):71-7. Kurhanewicz J, Vigneron D, Carroll P, Coakley F. PMID: 18090494.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    183. DNP-Hyperpolarized C Magnetic Resonance Metabolic Imaging for Cancer Applications. Appl Magn Reson. 2008; 34(3-4):533-544. Nelson SJ, Vigneron D, Kurhanewicz J, Chen A, Bok R, Hurd R. PMID: 20198109.
      View in: PubMed   Mentions:
    184. Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience. Magn Reson Med. 2007 Dec; 58(6):1099-106. Chen AP, Albers MJ, Cunningham CH, Kohler SJ, Yen YF, Hurd RE, Tropp J, Bok R, Pauly JM, Nelson SJ, Kurhanewicz J, Vigneron DB. PMID: 17969006.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansAnimals
    185. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology. 2008 Jan; 246(1):177-84. Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, Zhao S, Carroll PR, Yeh BM, Kurhanewicz J. PMID: 18024434.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    186. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. Radiology. 2007 Sep; 244(3):797-806. Testa C, Schiavina R, Lodi R, Salizzoni E, Corti B, Farsad M, Kurhanewicz J, Manferrari F, Brunocilla E, Tonon C, Monetti N, Castellucci P, Fanti S, Coe M, Grigioni WF, Martorana G, Canini R, Barbiroli B. PMID: 17652190.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    187. 3D MR spectroscopic imaging in the evaluation of prostate cancer. Clin Radiol. 2007 Oct; 62(10):921-9. Rajesh A, Coakley FV, Kurhanewicz J. PMID: 17765456.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    188. In vivo 13 carbon metabolic imaging at 3T with hyperpolarized 13C-1-pyruvate. Magn Reson Med. 2007 Jul; 58(1):65-9. Kohler SJ, Yen Y, Wolber J, Chen AP, Albers MJ, Bok R, Zhang V, Tropp J, Nelson S, Vigneron DB, Kurhanewicz J, Hurd RE. PMID: 17659629.
      View in: PubMed   Mentions: 80     Fields:    Translation:Animals
    189. Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. J Magn Reson. 2007 Aug; 187(2):357-62. Cunningham CH, Chen AP, Albers MJ, Kurhanewicz J, Hurd RE, Yen YF, Pauly JM, Nelson SJ, Vigneron DB. PMID: 17562376.
      View in: PubMed   Mentions: 83     Fields:    Translation:Animals
    190. High-speed 3T MR spectroscopic imaging of prostate with flyback echo-planar encoding. J Magn Reson Imaging. 2007 Jun; 25(6):1288-92. Chen AP, Cunningham CH, Ozturk-Isik E, Xu D, Hurd RE, Kelley DA, Pauly JM, Kurhanewicz J, Nelson SJ, Vigneron DB. PMID: 17520729.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    191. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol. 2007 Mar; 188(3):812-6. Costouros NG, Coakley FV, Westphalen AC, Qayyum A, Yeh BM, Joe BN, Kurhanewicz J. PMID: 17312072.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    192. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging. BJU Int. 2007 Jan; 99(1):41-5. Coakley FV, Chen I, Qayyum A, Westphalen AC, Carroll PR, Hricak H, Chen MH, Kurhanewicz J. PMID: 17227490.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    193. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience. Radiology. 2007 Feb; 242(2):483-9. Hom JJ, Coakley FV, Simko JP, Lu Y, Qayyum A, Westphalen AC, Schmitt LD, Carroll PR, Kurhanewicz J. PMID: 17179396.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    194. Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score. Eur Radiol. 2007 Feb; 17(2):371-8. Mueller-Lisse UG, Swanson MG, Vigneron DB, Kurhanewicz J. PMID: 16791635.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    195. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med. 2006 Jun; 55(6):1257-64. Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 16685733.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    196. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence. Magn Reson Imaging. 2006 Sep; 24(7):825-32. Chen AP, Cunningham CH, Kurhanewicz J, Xu D, Hurd RE, Pauly JM, Carvajal L, Karpodinis K, Vigneron DB. PMID: 16916699.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    197. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis. NMR Biomed. 2006 Apr; 19(2):188-97. Pels P, Ozturk-Isik E, Swanson MG, Vanhamme L, Kurhanewicz J, Nelson SJ, Van Huffel S. PMID: 16411280.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    198. Feasibility of magnetic resonance spectroscopy for evaluating fetal lung maturity. J Pediatr Surg. 2006 Apr; 41(4):768-73. Clifton MS, Joe BN, Zektzer AS, Kurhanewicz J, Vigneron DB, Coakley FV, Nobuhara KK, Swanson MG. PMID: 16567191.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    199. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level. Int J Radiat Oncol Biol Phys. 2006 May 01; 65(1):65-72. Pickett B, Kurhanewicz J, Pouliot J, Weinberg V, Shinohara K, Coakley F, Roach M. PMID: 16517094.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    200. Registration of MR prostate images with biomechanical modeling and nonlinear parameter estimation. Med Phys. 2006 Feb; 33(2):446-54. Alterovitz R, Goldberg K, Pouliot J, Hsu IC, Kim Y, Noworolski SM, Kurhanewicz J. PMID: 16532952.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    201. Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions. Radiology. 2006 Jan; 238(1):192-9. Hom JJ, Coakley FV, Simko JP, Qayyum A, Lu Y, Schmitt L, Carroll PR, Kurhanewicz J. PMID: 16373767.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    202. Magnetic resonance imaging and spectroscopy of prostate cancer. Rev Urol. 2006; 8 Suppl 1:S4-S10. Carroll PR, Coakley FV, Kurhanewicz J. PMID: 17021625.
      View in: PubMed   Mentions:
    203. Correlation of HR-MAS spectroscopy derived metabolite concentrations with collagen and proteoglycan levels and Thompson grade in the degenerative disc. Spine (Phila Pa 1976). 2005 Dec 01; 30(23):2683-8. Keshari KR, Lotz JC, Kurhanewicz J, Majumdar S. PMID: 16319755.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    204. Expandable and rigid endorectal coils for prostate MRI: impact on prostate distortion and rigid image registration. Med Phys. 2005 Dec; 32(12):3569-78. Kim Y, Hsu IC, Pouliot J, Noworolski SM, Vigneron DB, Kurhanewicz J. PMID: 16475755.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    205. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology. 2005 Sep; 236(3):903-10. Prando A, Kurhanewicz J, Borges AP, Oliveira EM, Figueiredo E. PMID: 16118169.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    206. Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T. Magn Reson Med. 2005 May; 53(5):1033-9. Cunningham CH, Vigneron DB, Marjanska M, Chen AP, Xu D, Hurd RE, Kurhanewicz J, Garwood M, Pauly JM. PMID: 15844147.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    207. Characterization of intervertebral disc degeneration by high-resolution magic angle spinning (HR-MAS) spectroscopy. Magn Reson Med. 2005 Mar; 53(3):519-27. Keshari KR, Zektzer AS, Swanson MG, Majumdar S, Lotz JC, Kurhanewicz J. PMID: 15723415.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    208. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med. 2005 Feb; 53(2):249-55. Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. PMID: 15678552.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    209. Improved signal to noise in high-resolution magic angle spinning total correlation spectroscopy studies of prostate tissues using rotor-synchronized adiabatic pulses. Magn Reson Med. 2005 Jan; 53(1):41-8. Zektzer AS, Swanson MG, Jarso S, Nelson SJ, Vigneron DB, Kurhanewicz J. PMID: 15690501.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    210. Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse. Clin Prostate Cancer. 2004 Dec; 3(3):174-81. Pucar D, Koutcher JA, Shah A, Dyke JP, Schwartz L, Thaler H, Kurhanewicz J, Scardino PT, Kelly WK, Hricak H, Zakian KL. PMID: 15636684.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    211. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology. 2004 Dec; 233(3):701-8. Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, Jones KD, Carroll PR, Kurhanewicz J. PMID: 15564406.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    212. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1047-55. Pickett B, Kurhanewicz J, Coakley F, Shinohara K, Fein B, Roach M. PMID: 15519774.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    213. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol. 2004 Oct; 183(4):1079-83. Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L, Yeh BM, Carroll PR, Kurhanewicz J. PMID: 15385308.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    214. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology. 2004 Nov; 233(2):441-8. Coakley FV, Teh HS, Qayyum A, Swanson MG, Lu Y, Roach M, Pickett B, Shinohara K, Vigneron DB, Kurhanewicz J. PMID: 15375223.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    215. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1196-207. Pouliot J, Kim Y, Lessard E, Hsu IC, Vigneron DB, Kurhanewicz J. PMID: 15234056.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    216. Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys. 2004 Jul 01; 59(3):665-73. Pickett B, Ten Haken RK, Kurhanewicz J, Qayyum A, Shinohara K, Fein B, Roach M. PMID: 15183469.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    217. Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology. 2004 Jan; 230(1):215-20. Dhingsa R, Qayyum A, Coakley FV, Lu Y, Jones KD, Swanson MG, Carroll PR, Hricak H, Kurhanewicz J. PMID: 14695396.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    218. Image registration for prostate MR spectroscopy using modeling and optimization of force and stiffness parameters. Conf Proc IEEE Eng Med Biol Soc. 2004; 2004:1722-5. Alterovitz R, Goldberg K, Kurhanewicz J, Pouliot J, Hsu IC. PMID: 17272037.
      View in: PubMed   Mentions: 1     Fields:    
    219. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol. 2003 Dec; 170(6 Pt 2):S69-75; discussion S75-6. Coakley FV, Qayyum A, Kurhanewicz J. PMID: 14610414.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    220. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med. 2003 Nov; 50(5):944-54. Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J. PMID: 14587005.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    221. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem. 2003 Apr 25; 278(17):15056-64. Zhao YG, Xiao AZ, Newcomer RG, Park HI, Kang T, Chung LW, Swanson MG, Zhau HE, Kurhanewicz J, Sang QX. PMID: 12586837.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    222. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging. 2002 Oct; 16(4):451-63. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. PMID: 12353259.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    223. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology. 2002 Apr; 223(1):91-7. Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, Carroll PR, Hricak H. PMID: 11930052.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    224. Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med. 2001 Dec; 46(6):1079-87. Schricker AA, Pauly JM, Kurhanewicz J, Swanson MG, Vigneron DB. PMID: 11746572.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    225. Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. Radiology. 2001 Nov; 221(2):380-90. Mueller-Lisse UG, Vigneron DB, Hricak H, Swanson MG, Carroll PR, Bessette A, Scheidler J, Srivastava A, Males RG, Cha I, Kurhanewicz J. PMID: 11687679.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    226. Spectroscopy in prostate cancer: hope or hype? Oncology (Williston Park). 2001 Nov; 15(11):1399-410; discussion 1415-6, 1418. Roach M, Kurhanewicz J, Carroll P. PMID: 11758871.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    227. Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging. Magn Reson Med. 2001 Jul; 46(1):49-57. Mueller-Lisse UG, Swanson MG, Vigneron DB, Hricak H, Bessette A, Males RG, Wood PJ, Noworolski S, Nelson SJ, Barken I, Carroll PR, Kurhanewicz J. PMID: 11443710.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    228. Brachytherapy for prostate cancer: endorectal MR imaging of local treatment-related changes. Radiology. 2001 Jun; 219(3):817-21. Coakley FV, Hricak H, Wefer AE, Speight JL, Kurhanewicz J, Roach M. PMID: 11376276.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    229. Single-voxel oversampled J-resolved spectroscopy of in vivo human prostate tissue. Magn Reson Med. 2001 Jun; 45(6):973-80. Swanson MG, Vigneron DB, Tran TK, Sailasuta N, Hurd RE, Kurhanewicz J. PMID: 11378874.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    230. Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials. Urology. 2001 Apr; 57(4 Suppl 1):124-8. Kurhanewicz J, Swanson MG, Wood PJ, Vigneron DB. PMID: 11295609.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    231. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. Cancer Invest. 2001; 19(5):510-23. Swanson MG, Vigneron DB, Tran TK, Kurhanewicz J. PMID: 11458818.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    232. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol. 2000 Aug; 164(2):400-4. Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J. PMID: 10893595.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    233. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med. 2000 Jan; 43(1):23-33. Tran TK, Vigneron DB, Sailasuta N, Tropp J, Le Roux P, Kurhanewicz J, Nelson S, Hurd R. PMID: 10642728.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    234. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia. 2000 Jan-Apr; 2(1-2):166-89. Kurhanewicz J, Vigneron DB, Nelson SJ. PMID: 10933075.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    235. The prostate: MR imaging and spectroscopy. Present and future. Radiol Clin North Am. 2000 Jan; 38(1):115-38, viii-ix. Kurhanewicz J, Vigneron DB, Males RG, Swanson MG, Yu KK, Hricak H. PMID: 10664669.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    236. Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn Reson Med. 2000 Jan; 43(1):17-22. Males RG, Vigneron DB, Star-Lack J, Falbo SC, Nelson SJ, Hricak H, Kurhanewicz J. PMID: 10642727.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    237. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology. 1999 Nov; 213(2):481-8. Yu KK, Scheidler J, Hricak H, Vigneron DB, Zaloudek CJ, Males RG, Nelson SJ, Carroll PR, Kurhanewicz J. PMID: 10551230.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    238. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. Radiology. 1999 Nov; 213(2):473-80. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J. PMID: 10551229.
      View in: PubMed   Mentions: 115     Fields:    Translation:Humans
    239. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys. 1999 Jul 01; 44(4):921-9. Pickett B, Vigneault E, Kurhanewicz J, Verhey L, Roach M. PMID: 10386651.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    240. In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors. J Magn Reson. 1998 Aug; 133(2):243-54. Star-Lack J, Spielman D, Adalsteinsson E, Kurhanewicz J, Terris DJ, Vigneron DB. PMID: 9716465.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    241. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology. 1998 Mar; 206(3):785-90. Kaji Y, Kurhanewicz J, Hricak H, Sokolov DL, Huang LR, Nelson SJ, Vigneron DB. PMID: 9494502.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    242. Detection of recurrent prostate cancer after cryosurgery. Curr Opin Urol. 1998 Mar; 8(2):83-6. Parivar F, Kurhanewicz J. PMID: 17035847.
      View in: PubMed   Mentions: 5     Fields:    
    243. High spatial resolution and speed in MRSI. NMR Biomed. 1997 Dec; 10(8):411-22. Nelson SJ, Vigneron DB, Star-Lack J, Kurhanewicz J. PMID: 9542738.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    244. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med. 1997 Aug; 38(2):311-21. Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB. PMID: 9256113.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    245. Improved solvent suppression and increased spatial excitation bandwidths for three-dimensional PRESS CSI using phase-compensating spectral/spatial spin-echo pulses. J Magn Reson Imaging. 1997 Jul-Aug; 7(4):745-57. Star-Lack J, Vigneron DB, Pauly J, Kurhanewicz J, Nelson SJ. PMID: 9243397.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    246. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology. 1996 Oct; 48(4):594-9. Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR. PMID: 8886066.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    247. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology. 1996 Aug; 200(2):489-96. Kurhanewicz J, Vigneron DB, Hricak H, Parivar F, Nelson SJ, Shinohara K, Carroll PR. PMID: 8685346.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    248. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR Am J Roentgenol. 1996 May; 166(5):1157-63. Chen M, Hricak H, Kalbhen CL, Kurhanewicz J, Vigneron DB, Weiss JM, Carroll PR. PMID: 8615261.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    249. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology. 1996 Mar; 198(3):795-805. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. PMID: 8628874.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    250. Prostate carcinoma: MR imaging findings after cryosurgery. Radiology. 1996 Mar; 198(3):807-11. Kalbhen CL, Hricak H, Shinohara K, Chen M, Parivar F, Kurhanewicz J, Vigneron DB, Carroll PR. PMID: 8628875.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    251. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology. 1995 May; 195(2):385-90. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, Weiss JM, Narayan P, Carroll PR. PMID: 7724756.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    252. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology. 1995 Mar; 45(3):459-66. Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P. PMID: 7533458.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    253. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. Radiology. 1994 Dec; 193(3):703-9. Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P, Carroll PR. PMID: 7972810.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCTClinical Trials
    254. 31P magnetic resonance spectroscopy after combined hyperthermia and radiation. Curr Eye Res. 1994 Feb; 13(2):151-6. Kurhanewicz J, Char DH, Stauffer P, Quivey JM, James TL. PMID: 8194362.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    255. 13-cis-retinoic acid-mediated growth inhibition of DU-145 human prostate cancer cells. Biochem Mol Biol Int. 1994 Jan; 32(1):1-12. Dahiya R, Boyle B, Park HD, Kurhanewicz J, Macdonald JM, Narayan P. PMID: 8012274.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    256. Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study. Magn Reson Med. 1993 Feb; 29(2):149-57. Kurhanewicz J, Dahiya R, Macdonald JM, Chang LH, James TL, Narayan P. PMID: 8429778.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    257. Effect of glucose and confluency on phosphorus metabolites of perfused human prostatic adenocarcinoma cells as determined by 31P MRS. Magn Reson Med. 1993 Feb; 29(2):244-8. Macdonald JM, Kurhanewicz J, Dahiya R, Espanol MT, Chang LH, Goldberg B, James TL, Narayan P. PMID: 8429789.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    258. Phosphorus metabolite characterization of human prostatic adenocarcinoma in a nude mouse model by 31P magnetic resonance spectroscopy and high pressure liquid chromatography. NMR Biomed. 1992 Jul-Aug; 5(4):185-92. Kurhanewicz J, Dahiya R, Macdonald JM, Jajodia P, Chang LH, James TL, Narayan P. PMID: 1449954.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    259. Magnetic resonance spectroscopy in prostate disease: diagnostic possibilities and future developments. Prostate Suppl. 1992; 4:43-50. Narayan P, Kurhanewicz J. PMID: 1374177.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    260. 31P spectroscopy of the human prostate gland in vivo using a transrectal probe. Magn Reson Med. 1991 Dec; 22(2):404-13. Kurhanewicz J, Thomas A, Jajodia P, Weiner MW, James TL, Vigneron DB, Narayan P. PMID: 1725918.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    261. 31P magnetic resonance spectroscopy (MRS) of experimental orbital myositis. Invest Ophthalmol Vis Sci. 1991 Jul; 32(8):2417-22. Winguth S, Kurhanewicz J, Wang ML, Quivey JM, James TL, Char DH. PMID: 2071353.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    262. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report. J Urol. 1991 Jul; 146(1):66-74. Narayan P, Jajodia P, Kurhanewicz J, Thomas A, MacDonald J, Hubesch B, Hedgcock M, Anderson CM, James TL, Tanagho EA. PMID: 1711587.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    263. 31P magnetic resonance spectroscopy of animal uveal melanoma. Invest Ophthalmol Vis Sci. 1990 Sep; 31(9):1745-53. Kurhanewicz J, Winguth SD, Char DH, Kaleta S, Kindy-Degnan N, Swift PS, Stauffer PR, Wendland MF, Lovato A, Chang LH. PMID: 2211022.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    264. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol. 1990 May; 11(3):423-9. Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, Asgari H, Norman D. PMID: 2161612.
      View in: PubMed   Mentions: 132     Fields:    Translation:Animals
    265. MRS of ischemic/hypoxic brain disease. Invest Radiol. 1989 Dec; 24(12):951-4. Kucharczyk J, Moseley M, Kurhanewicz J, Norman D. PMID: 2691441.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    John's Networks
    Concepts (513)
    Derived automatically from this person's publications.
    _
    Co-Authors (105)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _